Teva Pharmaceutical Industries Limited (TEVA)

NYSE: TEVA · Real-Time Price · USD

39.19

-1.03 (-2.56%)

At close: Sep 25, 2026, 4:00 PM EDT

39.19

0.00 (0.00%)

After-hours: Sep 25, 2026, 5:36 PM EDT

Teva Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	45,668	32,824	20,990	9,663	9,929	9,541
Market Cap Growth	104.68%	56.38%	117.22%	-2.68%	4.07%	-7.39%
Enterprise Value	58,907	47,716	37,265	28,294	30,075	32,651
Last Close Price	40.22	28.61	18.50	8.62	8.94	8.65

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	66.85	23.28	-	-	-	22.88
PS Ratio	2.63	1.90	1.27	0.61	0.67	0.60
PB Ratio	6.05	4.15	3.67	1.19	1.16	0.85
P/FCF Ratio	33.85	28.59	28.02	11.48	9.53	40.43
P/OCF Ratio	24.02	19.91	16.83	7.06	6.25	11.96

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	3.40	2.77	2.25	1.79	2.02	2.06
EV/EBITDA Ratio	13.79	9.63	8.41	6.52	7.58	7.41
EV/EBIT Ratio	17.94	12.07	11.05	8.88	11.30	10.60
EV/FCF Ratio	43.68	41.56	49.75	33.60	28.86	138.35

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	2.18	2.18	3.18	2.50	2.52	2.10
Debt / EBITDA Ratio	3.84	3.39	3.98	4.53	5.26	5.19
Debt / FCF Ratio	12.54	15.01	24.28	24.08	20.80	99.97
Net Debt / Equity Ratio	1.71	1.73	2.60	2.10	2.19	1.91
Net Debt / EBITDA Ratio	3.10	2.76	3.36	3.93	4.75	4.86
Net Debt / FCF Ratio	9.83	11.91	19.87	20.25	18.11	90.80
Asset Turnover	0.43	0.43	0.40	0.36	0.33	0.32
Inventory Turnover	2.45	2.69	2.41	2.09	2.08	2.02
Quick Ratio	0.46	0.54	0.50	0.54	0.57	0.61
Current Ratio	0.88	1.04	0.98	1.02	1.05	1.14
Return on Equity (ROE)	9.69%	20.79%	-28.30%	-7.36%	-25.19%	4.09%
Return on Assets (ROA)	5.13%	6.17%	5.09%	4.55%	3.63%	3.91%
Return on Invested Capital (ROIC)	15.21%	18.73%	14.74%	12.10%	8.85%	6.18%
Return on Capital Employed (ROCE)	13.50%	14.50%	12.70%	10.20%	8.20%	8.40%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	1.55%	4.30%	-7.81%	-5.79%	-24.63%	4.37%
FCF Yield	2.95%	3.50%	3.57%	8.71%	10.49%	2.47%
Buyback Yield / Dilution	-2.24%	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%
Total Shareholder Return	-2.24%	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%

SEC Filings: 10-K · 10-Q